Skip to search formSkip to main contentSkip to account menu

response to clopidogrel

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Low Response to Clopidogrel in Coronary Artery Disease.
BACKGROUND In patients with coronary artery disease, cardiovascular mortality and other acute events showed a clear correlation… 
2018
2018
Ticagrelor-induced Angioedema After Percutaneous Coronary Intervention in a Patient with a History of Ischemic Stroke and Low Response to Clopidogrel: A Rare Dilemma
Dual antiplatelet therapy (DAPT) is widely recognized as the mainstay of treatment after percutaneous coronary intervention (PCI… 
2017
2017
The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry
Introduction: Clopidogrel is an antiplatelet drug widely used in patients with acute coronary syndromes or stroke. Despite… 
2016
2016
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Dual antiplatelet therapy is empirically recommended following transcatheter aortic valve implantation (TAVI). The aims of the… 
2016
2016
Enhanced Platelet Response to Clopidogrel in Abcc3-deficient Mice Due to Its Increased Bioactivation
Abstract: Resistance of the patient to clopidogrel (an inactive prodrug) has been recently reported to be associated with… 
2015
2015
The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin.
Clopidogrel and aspirin are commonly prescribed anti-platelet medications indicated for patients who have experienced, or are at… 
2015
2015
CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome
Background:To investigate the contributions of CYP2C19 polymorphisms to the various clopidogrel responses tested by… 
2014
2014
Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients with Coronary Artery Disease
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosis in coronary artery disease… 
2010
2010
Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability
The anti-platelet agent clopidogrel bisulfate (sold under the trade name Plavix in the United States) is a widely prescribed… 
2005
2005
Inter-individual variability in response to clopidogrel in patients with coronary artery disease.
BACKGROUND Clopidogrel, especially when combined with aspirin, reduces the rate of ischaemic events in patients with coronary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)